You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 4, July 25, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Nutrition/ Malnutrition
 •Statistics and Research Methods
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antioxidant Supplements and Mortality

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We have several concerns about the meta-analysis of randomized trials of antioxidant supplements by Dr Bjelakovic and colleagues.1 First, establishing causality requires considering temporal relationship, dose-response relationship, evidence of supplement use, effects that disappear after discontinuation of supplementation, lack of alternative explanations, and recurrence after restarting supplement use. It is difficult to establish a causal relationship between supplement use and risk of death when 2 of the criteria (response to rechallenge and response to discontinuation of use) cannot be applied to the outcome of death. Hence, greater reliance must be placed on plausible biological mechanisms and evidence that nutrients affect specific disorders. As the authors pointed out, it is likely that increased cancer and cardiovascular mortality are the main reasons for the increased all-cause mortality. The review would have been more convincing if it had also addressed cause-specific mortality.

Second, the exclusion of 405 studies with no . . . [Full Text of this Article]

Han-Yao Huang, PhD, MPH
han-yao_huang@merck.com

Steven Teutsch, MD, MPH
Outcomes Research and Management
Merck & Co, Inc
West Point, Pennsylvania

Eric Bass, MD, MPH
Department of Medicine
Johns Hopkins School of Medicine
Baltimore, Maryland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Antioxidant Supplements and Mortality
Demetrius Albanes
JAMA. 2007;298(4):400.
EXTRACT | FULL TEXT  

Antioxidant Supplements and Mortality
Harri Hemilä
JAMA. 2007;298(4):401.
EXTRACT | FULL TEXT  

Antioxidant Supplements and Mortality
Philip R. Taylor and Sanford Dawsey
JAMA. 2007;298(4):401-402.
EXTRACT | FULL TEXT  

Antioxidant Supplements and Mortality—Reply
Lise Lotte Gluud, Goran Bjelakovic, Dimitrinka Nikolova, Rosa G. Simonetti, and Christian Gluud
JAMA. 2007;298(4):402-403.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
Goran Bjelakovic, Dimitrinka Nikolova, Lise Lotte Gluud, Rosa G. Simonetti, and Christian Gluud
JAMA. 2007;297(8):842-857.
ABSTRACT | FULL TEXT  

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):56-65.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.